Article
BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin.
Cancer science - 1 May 2010
Shim Hyun Jeong, Yun Joo Young, Hwang Jun Eul, Bae Woo Kyun, Cho Sang Hee, Lee Ji Hee, Kim Hee Nam, Shin Min Ho, Kweon Sun Seog, Lee Jae Hyuk, Kim Hyeoung Joon, Chung Ik Joo
Abstract excerpt
This study evaluated the influence of genetic polymorphism influencing drug metabolism on survival in taxane- and cisplatin-treated advanced gastric cancer (AGC). Peripheral blood samples from 207 AGC patients treated with first-line chemotherapy of taxane and cisplatin were used. We investigated polymorphisms that influenced the metabolism of taxane (ATP-binding cassette transporter B1 (ABCB1)), cisplatin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
